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Abstract
The pancreas gland is composed of both exocrine and endocrine components. 
The endocrine component regulates blood sugar levels and the exocrine component 
produces digestive enzymes that are secreted into the small intestine to aid in 
digestion. The pancreas must balance the production of new enzymes with the 
release of active enzymes. Enzyme production begins in the ER and undergoes 
modification in the golgi apparatus where inactive enzymes are packaged in vesicles. 
The vesicles dock with the plasma membrane and are secreted into the small intestine 
after food triggers the release of activating hormones. Although these mechanisms 
outlining both production and release are known, coordination between the two 
processes remains undetermined.
The present project was developed on the hypothesis that the cytoskeleton 
contributes to the coordination between enzyme production and release. The 
cytoskeleton has historically been associated with maintaining cell structure and 
facilitating movement; however, recent studies have shown cytoskeletal elements 
attached to nonstructural proteins and signaling molecules. The present results show 
that ERK phosphorylation decreases when microtubules are depolymerized with 
cholchicine. However, inhibition of myosin ATPase activity by 2,3-butanedione 
monoxime (BDM) causes an increase in ERK phosphorylation and a decrease in 
secretion. Data with the myosin motor protein inhibitor ML-9 also showed an increase 
in ERK phosphorylation but a decrease when intracellular calcium was increased.
The results support the requirement for the cytoskeleton system in pancreatic 
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ABSTRACT
The pancreas gland is composed of both exocrine and endocrine components. 
The endocrine component regulates blood sugar levels and the exocrine component 
produces digestive enzymes that are secreted into the small intestine to aid in 
digestion. The pancreas must balance the production of new enzymes with the 
release of active enzymes. Enzyme production begins in the ER and undergoes 
modification in the golgi apparatus where inactive enzymes are packaged in vesicles. 
The vesicles dock with the plasma membrane and are secreted into the small intestine 
after food triggers the release of activating hormones. Although these mechanisms 
outlining both production and release are known, coordination between the two 
processes remains undetermined.
The present project was developed on the hypothesis that the cytoskeleton 
contributes to the coordination between enzyme production and release. The 
cytoskeleton has historically been associated with maintaining cell structure and 
facilitating movement; however, recent studies have shown cytoskeletal elements 
attached to nonstructural proteins and signaling molecules. The present results show 
that ERK phosphorylation decreases when microtubules are depolymerized with 
cholchicine. However, inhibition of myosin ATPase activity by 2,3-butanedione 
monoxime (BDM) causes an increase in ERK phosphorylation and a decrease in 
secretion. Data with the myosin motor protein inhibitor ML-9 also showed an increase 
in ERK phosphorylation but a decrease when intracellular calcium was increased.
The results support the requirement for the cytoskeleton system in pancreatic 
W  signalling and that the microfilaments are necessary for the coordination of production 
and exocytotic release.
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Multicellular organisms sustain function through complex biochemical pathways 
that coordinate multiple interrelated cellular events. Detailed steps outlining the 
sequential activity of many biochemical pathways have been identified scientifically, 
however the means of coordination between simultaneous events remains 
undetermined. The mammalian pancreas presents such a model for cellular 
coordination. To ensure enzyme secretion, the pancreas must balance the production 
of new enzymes with the release of active enzymes. Individually, regulation of enzyme 
release and production has been determined, but coordination between the two is 
unclear.
The pancreas is a digestive gland that contains both exocrine and endocrine 
components. The endocrine component releases the hormones insulin, glucagon, 
and somatostatin into the blood stream to regulate blood sugar levels. The exocrine 
component produces and releases digestive enzymes and alkaline buffers to aid in 
digestion. The exocrine cells are made up of acinar cells and ductal epithelial cells. 
Combined, these ceils release an alkaline fluid secretion into the duodenum through 
the pancreatic duct. The fluid secretion contains an assortment of digestive enzymes 
that hydrolyze ingested macromolecules into subunits the body can then absorb.
Secretions of the exocrine pancreas are regulated by hormones released by 
the duodenum. As acidic chyme passes from the stomach to the small intestine, the 
duodenum releases the hormones secretin and cholecystokinin (CCK). Secretin 
stimulates the release of an alkaline fluid which neutralizes the acidic chyme. 
Furthermore, digestive enzymes are denatured by acid and therefore function better in
the slightly alkaline conditions. CCK Is the primary hormone responsible for 
stimulating the pancreas to produce and release the digestive enzymes from acinar 
cells.
In greater detail, CCK stimulates acinar cells through a G-protein-coupled 
receptor to increase intracellular calcium and elicit amylase secretion (Torgerson and 
McNiven, 1999). As CCK binds to an extracellular plasma membrane receptor, the 
signal is transduced by a guanine nucleotide-binding protein (G-Protein). These 
transducers transmit an external stimuli to an internal cytoplasmic enzyme. When 
CCK binds to its receptor, a conformational change occurs within the receptor which 
subsequently activates the G-protein, Gq, located on the cytoplasmic side of the 
plasma membrane. The inactive form of Gq is bound to GDP and when CCK binds to 
its receptor, Gq releases GDP and binds GTP. The a-subunit of the Gq-G-protein
dissociates from the Gq complex after GTP binds. The subunit is then free to move 
along the plasma membrane until it encounters and activates the effector enzyme 
phospholipase C (PLC). Also located on the cytofacial side of the membrane, PLC 
hydrolyses the membrane phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2)
to inositol 1,4,5-trisphosphate (IP,) and diacylglycerol (DAG). Both IP, and DAG act aso 3
second messengers transmitting the message deep into the acinar cell.
Once released, IP3 travels through the cytoplasm until it binds to a calcium
channel located on the surface of the endoplasmic reticulum (ER). IP, binding causes
the calcium channels to open. Calcium stored within the ER lumen diffuses out of the 
calcium channels and increases cytosolic calcium concentration (Figure 1). The
wFigure 1. A model of CCK stimulating the CCK receptor resulting in binding of IP3 to 
the calcium channels located on the ER. CCK binds to a G-protein-coupled receptor 
promoting Gq activation. Gqa binds GTP and activates PLC. PLC hydrolyses PIP2, 
yielding IP3 and DAG. IP3 travels through the cytoplasm, binds to a calcium channel 






increase in calcium concentration acts as an intracellular messenger which drives 
vesicles to fuse with the plasma membrane and release their contents. This calcium 
signal attenuates as calcium is pumped back into the ER lumen.
The second messenger DAG remains associated with the plasma membrane 
and activates protein kinase C (PKC). PKC remains inactive until increases in 
cytosolic calcium concentration, from IP0, causes conventional PKC to bind to the
cytosolic side of the plasma membrane where DAG then activates it. PKC belongs to 
the serine-threonine kinase family and exists in three forms based on the requirement 
for activation: conventional, novel, or atypical. Conventional PKC requires DAG and 
calcium to activate, novel PKC does not require calcium but does require DAG, and 
atypical PKC requires neither calcium or DAG to activate. The activation of PKC 
controls the downstream extracellular signal-related kinase (ERK) activity (Figure 2). 
ERK causes the phosphorylation of transcription factors which leads to the production 
of mRNA and synthesis of digestive enzymes.
Acinar cells release digestive enzymes into the duodenum after they have 
undergone modification and then exocytosis. Following the production of mRNA, 
enzymes are synthesized in the rough endoplasmic reticulum (RER) and then 
transported to the cis face of the goigi apparatus. These enzymes are inactive 
precursors known as zymogens. Transport vesicles surrounding the zymogens bud off 
the RER and fuse with the goigi apparatus membrane facing the nucleus. Once inside 
the goigi apparatus, zymogens are modified and moved from saccule to saccule by 
transfer vesicles. Finally, the zymogens bud off the trans goigi membrane as secretory 
vesicles. These vesicles then fuse with the plasma membrane and eject the
Figure 2. A model for PKC activation of the ERK signalling Cascade. Increases in 
cytosolic calcium causes conventional PKC to bind to the PM where DAG activates it. 
PKC activation leads to the downstream activation of the ERK signaling cascade, 
mRNA production, and synthesis of enzymes.

8zymogens into the duodenum (Figure 3). The zymogens are then converted into 
active digestive enzymes by secreted intestinal proteases.
Versicies released by the golgi apparatus walk or slide along complex 
cytoskeletal arrangements as they are directed to fuse with the plasma membrane.
The cytoskeleton is made up of protein fibers that support cell structure and aid in 
organelle movement. The cytoskeleton consists of three main groups: microfilaments, 
microtubies, and intermediate filaments.
Microfilaments are composed of highly conserved actin polymers that aid in 
secretory vesicle transport. Actin exists in a globular form, g-actin, and in a 
filamentous form, F-actin. G-actin polymerizes into f-actin with the introduction of an 
ion signal. Since each actin subunit maintains a polarity, the actin filament is 
W  designated with a positive end and a negative end. Polymerization occurs at each 
end, but elongates faster at the positive end. As the filament lengthens, all ATP is 
hydrolyzed into ADP and Pi, except the terminal ATP. To further stabilize and prevent 
depolymerization, actin binding proteins attach to the positive and negative ends of the 
filament and form a cap.
There are three classes of actin; a, p, and y actin. The a-actin class has a
subtype for skeletal, cardiac, and smooth muscle while p-actin and y-actin are found in
nonmuscular tissue like kidney and liver cells. Actin filaments are arranged in either
structural bundles or networks. Bundles arrange filaments in parallel lines, while two
types of networks crisscross filaments. The webbed planar network associates with
the plasma membrane, whereas a cytosolic network creates a gel-like structure. Both
w
Figure 3. A model for zymogen production and transportation. Following the 
production of mRNA, inactive enzymes, or zymogens, are synthesized in the RER. 
Zymogens are then sent to the golgi apparatus, via transfer vesicles, where they are 
modified and organized into secretory vesicles. Vesicles are then either shipped to 
the PM, where they undergo exocytosis and enter the small intestine, or fuse with a 




bundles and networks hold filaments together with a series of specific actin cross- 
linking proteins.
Cellular movement is achieved with the action of an ATPase myosin enzyme 
moving along an actin filament. Two types of myosin, myosin I and myosin 11, are 
composed of both a heavy chain and a light chain. The heavy chain has a head 
domain which binds ATP, a neck domain which associates with the light chain, and a 
tail domain that contains binding sites to determine myosin activity. Myosin head 
domains move against actin filaments in combination with ATP hydrolysis. In the 
absence of bound ATP, myosin binds to actin. ATP then binds to a specialized ATP- 
binding pocket on myosin 11, which causes a conformational change at the actin- 
binding site. Myosin detaches from actin and hydrolyses ATP. Myosin then reforms 
into an energized position closer to the positive end of the filament and rebinds with 
actin. The inorganic phosphate dissociates from myosin causing the energized 
myosin to rotate and pull actin along with it. In muscle sarcomeres, myosin remains 
stationary and pulls actin, in nonmuscle systems, actin remains still and myosin walk 
along the filament.
Cytoskeletal organization and migration have been linked to the Rho family 
GTPases. Rho family GTPases include 14 members and cycle between GTP and GDP 
to organize microfilaments. The GTPases are regulated by guanine nucleotide 
exchange factors and guanine nucleotide dissociation inhibitors that modulate 
exchange between GTP and GDP (Schwartz and Shattil, 2000). GTPase-activating 
proteins negatively inhibit GTP activity by promoting GTP hydrolysis. Rho kinases 
W  (ROK) stimulate myosin by directly phosphorylating the myosin light chain or by
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phosphorylating myosin light chain phosphatatses. The phosphatase inactivates and 
myosin activity increases. The ROK contains a lipid binding site and remains localized 
to the membrane.
Microtubules, the second of three groups that make up the cytoskeleton, 
combine globular monomers of the protein tubulin together to form cylindrical tubes.
Tubulin, a heterodimeric GTPase, binds GTP to both an a- and p-tubulin subunit, but 
only the p-tubulin binding site can hydrolyse GTP to GDP. Tubulin monomers produce 
a protofiiament by arranging alternating a- and p-tubulin subunits in longitudinal rows.
Thirteen protofiiaments combine to form a simple tube called a singlet microtubule. 
Doublet and triplet microtubules also exist, with one main 13-protofilament microtubule 
W  and an additional one or two 10-protofiiament microtubule. Microtubules, like actin
microfilaments, also have a polarity which distinguishes a positive from a negative end 
(Kraemer et at., 1998). Microtubules structurally situate themselves so that the positive 
ends face away from a microtubule-organizing center (MTOC). In animals, the MTOC
is a centrosome which can contain a pair of centrioles. The proteins y-tubulin and
pericentrin, necessary to initiate microtubule assembly, are also located within the 
MTOC.
Microtubules quickly assemble or disassemble their structure in three steps.
First, ap-tubulin subunits will organize longitudinally into protofiiaments. Second, 
protofiiaments associate laterally and form the walls of a singlet microtubule. Then, if 
ap-tubulin subunits reach a specific concentration, microtubules will elongate with the
W''
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addition of extra subunits. After p-tubulin attaches to the growing microtubule, the GTP
hydrolyses to GDP. If polymerization occurs faster than the hydrolysis of GTP, a cap of 
GTP-bound subunits will be added to the positive end. Polymerization of microtubules 
occurs faster at the positive end then at the negative end, so capping is not necessary
at the negative end. If the level of ap-tubulin subunits decreases below the critical
concentration, microtubules will depoiymerize. Microtubule-associated proteins
(MAPs) further stabilize microtubules by cross-linking to other microtubules,
microfilaments, and by preventing depolymerization.
The motor proteins kinesin and dynein transport vesicles along microtubles.
Kinesin moves along microtubules in the positive direction whereas dynein moves in
the negative direction. Kinesin has two heavy chains which each connect to two light
chains. A large dimeric head domain binds to microtubules and ATP hydrolysis
generates the motor activity. A tail domain binds to the vesicle being transported.
Dynein are large multimeric proteins with two heavy chains forming the head domain
and two light chains forming the tail domain. Unlike kinesin, dynein needs the
assistance of a microtubules-binding protein, such as dynactin, to mediate transport.
Pancreatic cells have the responsibility of producing enzymes, secreting
enzymes, and coordinating the two pathways so that production does not exceed
release, or release exceed production. Enzyme production results from gene
transcription, mRNA synthesis, and eventual protein translation. Enzyme secretion is
stimulated by an increase in intracellular calcium concentration, but how are the two
coordinated? The cytoskeleton supplies a network that might be able to communicate 
w
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relative status between the two intracellular events. Previous reports have shown that 
zymogen granules require an intact microtubule system to dock with the cell surface 
(Kraemer et al., 1998), and that secretion is in some way governed by the actin 
cytoskeleton (Torgerson and McNiven, 2000). In the present study, using techniques 
and equipment available to me, I manipulated the cytoskeletal networks with known 
pharmacological agents while simultaneously measuring the physiological activity of 
relevant proteins. I determined whether the microfilament and microtubules networks 




Isolation of Pancreatic Acini
Pancreatic tissue removed from male Sprangue-Dawley rats served as the 
source for isolated pancreatic acini. After light ether anaesthesia, the rats underwent 
cervical dislocation, a procedure approved by the NIU IACUC committee. The 
pancreas was then dissected from the rat, minced thoroughly, and placed into 20 ml of 
Hank’s growth media (Medium 199), including; 10 mM N-2-hydroxyethylpiperazine-N- 
2-ethanesulfonic acid (HEPES), 1 mg/1 ml bovine serum albumin (BSA), trypsin 
inhibitor (0.1 mg/ml), and 0.1 mM phenyl methyl sulfonyl fluoride (PMSF). The 
w  pancreatic cells were washed two times in 20 ml of medium. Pancreatic cells were 
next separated into appropriate experimental groups, re-suspended in 20 ml of 
medium, and placed into a 37°C shacking water bath prior to experimental treatment.
Chemicals
All necessary reagents, antibodies, agonists, and inhibitors for this project were 
purchased from various biochemical companies in the United States. Medium 199 
(Gibco BRL, Inc. Grand Island, NY), used to wash and incubate pancreatic cells also 
contained , HEPES (Sigma Chemical Company, St. Louis, MO), BSA (Sigma 
Chemical Company), the protease inhibitor PMSF (Sigma Chemical Company), and 
trypsin inhibitor (Gibco BRL, Inc.), which inhibits the serine proteases and trypsin.
Protein A agarose beads were purchased from Boehringer Mannheim and were used 
to immunoprecipitate proteins following their experimental treatments.
The physiological agonist for pancreatic secretion, cholecystokinin, was 
purchased from Calbiochem-Novabiochem Corp. LaJoila, CA. The cytoskeleton 
affecting agent, cytochalasin D (Sigma Chemical Company) inhibits microfilament 
polymerization. Colchicine (Sigma Chemical Company) prevents polymerization of 
microtubules. To inhibit myosin 11, 2 ,3-butanedione monoxime was used as well as 
1-(5 -chloronapthalene-1-sulfonyl)-1H-hexahydro-1,4diazephine (ML-9) a myosin light 
chain kinase inhibitor. Both were purchased from Sigma Chemical Company. 
Thapsigargan, purchased at Calbiochem-Novabiochem Corp., was used to inhibit the 
calcium uptake in cells.
Primary antibodies including polyclonal mouse anti-phosphotyrosine lgG2b, 
polyclonal rabbit anti-ERK1 IgG, polyclonal rabbit anti-ERK2 IgG, and polyclonal rabbit 
anti-PI3K IgG were purchased from Santa Cruz Biotechnology, Inc. Horseradish 
peroxidase labeled anti-rabbit IgG secondary antibody was also purchased from 
Santa Cruz Biotechnology, Inc.
Treatment of Pancreatic Acini
Pancreatic acinar cells were experimentally treated at 37°C in a shaking water 
bath. Agonists and/or inhibitors were either massed out or diluted from solubilized 
concentrated stock solutions and placed directly into the cell suspension. Treated 
pancreatic cells then underwent a 30 minute assay to determine the rate of exocytotic
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secretion or alternatively were placed in an IEC-Centra-8R centrifuge at 50 g for two 
minutes for centrifugation at room temperature. The resulting pellet was lysed, 
washed, and subjected to immunoprecipitation of tyrosine-phosphorylated proteins.
immunoprecipitation
Tyrosine phosphorylated proteins were extracted from the pancreatic acinar 
lysates by standard immunoprecipitation protocols. Acinar cell fractions were 
suspended and solubilized by homogenization (glass-Teflon potter) in an 
immunoprecipitation buffer containing 150 mM NaCI, 50 mM Tris-HCI [pH 7.5], 1% 
Nonidet P40, 0.5% deoxycholic acid, 2mM sodium orthovanidate, 1.4 mM TPCK, 0.1 
w  mM leupeptin, 1mg/m! SDS, and 1 mg/ml 0.1 mM trypsin inhibitor and 0.1 mM PMSF. 
The suspension was clarified by centrifugation at 12,000 g for 10 minutes. The 
supernatant was removed and incubated with 6 /vl of phosphotyrosine antibody for one 
hour. Antibody was subsequently harvested by adding 15 //I of protein-A agarose to 
each sample. The samples incubated overnight at 4°C , or for a period of six hours, on 
a rotator to maintain suspension of agarose beads. Protein bound to the agarose- 
conjugated phosphotyrosine antibody were collected by centrifugation at 12,000 g for 
30 seconds. The agarose beads containing the bound antibody and tyrosyl 
phosphorylated proteins were washed three times in immunoprecipitation buffer for 20 
minutes at 4°C. To remove additional nonspecifically bound proteins, the beads were 
then washed three times in a high salt buffer (500 mM NaCI, 50 mM Tris-Hcl [pH 7.5], 
0.1% Nonidet P40) and collected by centrifugation at 12,000 g for 30 seconds. The
18
beads were then washed three more times in alow salt buffer (50 mM Tris-Hcl [pH 
7.5], 0.1% Nonidet P40) and again collected by centrifugation at 12,000 g for 30 
seconds. Finally, the protein-antibody complexes were dissociated from each other as 
well as the agarose beads by heating for ten minutes (95°C) in Laemmli reducing 
buffer (65.2 mM Tris-HCL [pH 6.8], 25% glycerol, 2% SDS, 0.01% bromophenol blue,
and 710 mM p-mercaptoethanol). The suspension was then centrifuged at 12,000 g
for 30 seconds, and the supernatant (containing all tyrosine phosphorylated proteins) 
was removed and aliquoted into 20 fj\ samples and stored at -80°C.
Protein Assay
Protein was assayed using the Bio-Rad Bradford Protein Assay Kit with bovine 
serum albumin as a standard. Protein fractions were incubated in 2 ml of a 1:4 dilution 
of protein dye stock solution for 15 minutes at room temperature. Absorbencies were 
measured at wavelength of 595 nm with a Beckman DU-60 spectrophotometer.
Amylase Assay
Amylase assays were performed by a modified version of Bernfeld (1955), to 
determine the extent of secretion from the pancreatic acini during treatment. Maltose 
was used as a disaccharide standard. Samples, 25 fj\ and 50 fj\, were incubated with 
75 fj\ and 50 y\ of resuspension buffer respectively (0.2% Triton X-100, 50 mM Tris, 
w  100 mM NaCI, and 10 mM CaCI2) and 100 y\ substrate (1% amylopectin, 40 mM
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MOPS, 60 mM NaCI) for 30 minutes in a shacking 37°C waterbath. This reaction was 
stopped with the addition of 0.2 ml stop-development reagent (1% 3,5-dinitrosalicylic 
acid, 0.4 N NaOH, 1.06 M sodium potassium tartarate). The resulting fractions were 
heated for 7 minutes at 95°C in a dry bath. The fractions were cooled and diluted with 
2.6 mi of water. Individual absorbencies were read with a Beckman DU-60 
spectrophotometer at a wavelength of 530 nm. Amylase release was then plotted as a 
function of time.
Electrophoresis and Electroblotting
Tyrosine phosphorylated proteins, already solubilized in iaemmli buffer, were 
w  removed from -80°C storage and heated (95°C) for 10 minutes. After cooling, equal 
amounts of protein from each sample were loaded on a discontinuous SDS- 
polyacrylamide gel (gel composition of 4% acrylamide/bis-acrylamide in the stacking 
gel and 12% acrylamide/bis-acrylamide in the separating gel). The samples were 
electrophoresed at 110 volts for 60 - 90 minutes. After electrophoresis, gels and 
nitrocellulose sheets were equilibrated for 10 minutes in transfer electrode buffer (192 
mM glycine, 20 mM Tris, 20% methanol) to remove extraneous salts and detergents 
from the gei and to uniformly wet the nitrocellulose. Proteins were then electroblotted 
onto a nitrocellulose membrane for 1 hour at 100 volts at 4°C. The electroblot was 
performed with the Mini-Trans electroblotting apparatus (Bio-Rad Laboratories).
20
Western Blotting and Enhanced Chemiluminescence (ECL)
After electrobiotting, unoccupied reactive sites on the nitrocellulose sheet were 
blocked with 10% nonfat dry milk in TTBS (250 mM NaCI, 20 mM Tris [pH 7.6], 0.05% 
Tween-20, for ERK2, or 500 mM NaCI, 20 mM Tris [pH 7.6], 0.05 Tween-20, for She 
and PI3K) for one hour at room temperature on a rocker. Following blocking, 
nitrocellulose blots were washed six times by incubating in 20 mi of a TTBS solution 
for five minutes at room temperature. After washing, nitrocellulose blots were 
incubated on a rocker overnight at 4°C of for one hour at room temperature in a 
solution containing 1% non-fat dry milk in specific salt concentration TTBS and a 
primary antibody. A 1:000 dilution was used for either stock polyclonal rabbit anti-Shc 
W  or ERK2, and a 1:4000 dilution was used for polyclonal rabbit anti-PI3K. The blots 
were then washed six times for five minutes with TTBS at room temperature on a 
rocking platform.
Primary antibody binding to proteins was detected using a 1:2000 dilution of 
stock horseradish peroxidase labeled anti-rabbit IgG. The blot was incubated with the 
secondary antibody in 1% nonfat dry mil in TTBS for one hour at room temperature on 
a rocking platform. Following the incubation with the secondary antibody, the blots 
were washed with TTBS six times for five minutes at room temperature. After the final 
wash, the blots were exposed to luminol developer solution (equal volumes of cyclic 
diacylhydrazide luminol and alkaline enhancer). This method relied upon the ability of 
bound horseradish peroxidase to oxidize the luminol and thereby excite the cyclic 
diacylhydrazide to a higher energy state. Once excited, the activated compound
21
decays to a lower energy state and emits a photon of light in the process (wavelength 
max = 428 nm). The chemiluminescence was detected using blue light-sensitive 
autoradiographic ECL hyperfilm in a darkroom. This exposer was performed in 
standard film-holding cassettes for 30 seconds to 30 minutes, depending on which 
antibody was being used and the amount of the starting sample. The exposed 
Hyperfilm was then developed and fixed in an automated film developer.
Image Scanning and Qualification
Following western blotting and enhanced chemiluminescence, protein bands 
on the ECL film were acquired using the computer program Adobe Photoshop 5.0. 
w  These scanned protein bands were then quantified using the computer program NIH 
Image 1.61.
To determine the correlation between cytoskeletal elements and exocytotic 
secretion, pharmacological agents were added to pancreatic acinar ceils to alter the 
formation of microtubules and microfilaments. Isolated pancreatic acinar cells were 
treated with the physiological agonist CCK, known to stimulate activation of 
intermediates in the ERK signaling pathway (Dabrowski et al., 1997). Another group of
pancreatic acinar cells from the same preparation were treated with 30 pM colchicine
to disrupt the microtubule network prior to CCK stimulation. Cells were 
immunoprecipitated with anti-phosphotyrosine antibody and probed using antibodies 
specific for ERK1, ERK2, or PI3K. Western Blot analysis revealed that CCK induces a 
33% rise in ERK1 phosphorylation when compared to a control that received no 
treatment. Significantly, cells pre-treated with colchicine show virtually no CCK 
induced ERK1 phosphorylation (Figure 4). These results were verified in other 
experiments whereby CCK reproducibly increased the level of ERK phosphorylation 
and when pre-treated with cholchicine, prevented ERK phosphorylation (Table 1). In 
contrast, when PI3K phosphorylation was monitored as opposed to ERK, the results 
were significantly different, with colchicine causing no inhibition of CCK induced PI3K 
phosphorylation. This suggests that the role of microtubules is distal to PI3K in the 
signalling cascade.
To test whether movement along microfilaments is a requirement for signal 
transduction, two drugs that inhibit the Myosin II ATPase motor protein were employed. 
The reagent BDM specifically inhibits the contraction of vertebrate muscle and
CON CCK COL
Figure 4. Pancreatic acinar cells treated in colchicine and CCK show no ERK 
phosphorylation compared to the increased phosphorylation that occurs when cells 
are only stimulated with CCK.
\ y /
Table 1. The figure shows the change in the level of tyrosyl phosphorylation after 
stimulation with CCK and treatment with 30 mM colchicine for 30 minutes, in 
comparison to cells treated only with CCK. ERK showed virtually no phosphorylation, 




reversibly affects myosin function and influences the intracellular concentration of 
calcium (Steinberg and McIntosh, 1998). isolated pancreatic acinar cells were treated 
with 10 mM BDM for 10 minutes prior to stimulation with CCK. Cells were 
immunoprecipitated with anti-phosphotyrosine antibody and probed using antibodies 
specific for ERK2, She, or PI3K. Western Blot analysis reveals that CCK stimulated 
cells alone raise ERK2 phosphorylation by 300% whereas cells treated with 
thapsigargan, a drug that selectively increases intracellular calcium concentration, 
caused a 110% increase in ERK2 phosphorylation. Cells treated with BDM and CCK 
increase ERK2 phosphorylation by 45%, in the presence of thapsigargan and 
compared to CCK alone. Analysis specific for She shows a 41% phosphorylation with 
CCK, an increase of an additional 42% in phosphorylation when cells were pre- 
W  treated with BDM, CCK, and thapsigargan, whereas thapsigargan alone promoted 
ERK phosphorylation to levels similar to that of CCK treatment. Likewise PI3K 
phosphorylation also increased in cells when pre-treated with BDM, compared to CCK 
and thapsigargan alone (Table 2).
To determine whether inhibition of myosin motor proteins had a proportional 
effect on the exocytotic branch of the signally system, the rate of pancreatic amylase 
release was measured. Isolated cells were either stimulated with CCK or treated with 
10 mM BDM and then stimulated with CCK. Total amylase release was measured 
over the course of 30 minutes and compared to a sample of untreated cells. The 
untreated cells released 10% of the total amylase over the course of 30 minutes, which 
is within normal experimental ranges. Cells stimulated with CCK responded with a 





















Table 2. The effect of BDM on the tyrosyl phosphorylation of ERK, She, and PI3K, in 
the presence of thapsigargan and compared to cells only stimulated with CCK. Cells 
pre-treated with BDM and CCK showed a 45% phosphorylation of ERK, a 42% 
phosphorylation of She, and a 48% phosphorylation of PI3K. These were increases in 
tyrosyl phosphorylation compared to cells treated only with CCK.
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course of 30 minutes. However, ceils treated with BDM prior to stimulation with CCK 
produced only a 10% release of total amylase, which is almost identical to the amylase 
release of non-treated cells (Figure 5). These results suggest the activity of myosin 
motor proteins are required for exocytosis, but down-regulates the ERK transcription 
branch of cell coordination.
To further investigate whether movement along microfilaments is necessary for 
signal transduction, myosin light chain kinase was inhibited by treating cells for 15
minutes with 30 m-M ML-9. An initial experiment first treated isolated cells with CCK,
and then isolated cells with both CCK and ML-9. Cells were immunoprecipitated with 
anti-phosphotyrosine antibody and probed using antibodies specific for ERK2 and 
PI3K. Cells stimulated with CCK alone showed a dramatic 431% increase in ERK2 
phosphorylation compared to cells that underwent no treatment. Cells treated with 
both CCK and ML-9 showed a 13% increase in ERK2 phosphorylation compared to 
cells stimulated only with CCK. Likewise, ML-9 increased CCK induced PI3K 
phosphorylation by 26% compared to cells stimulated only with CCK (Table 3). A 
second experiment added thapsigargan to CCK stimulated ceils treated with ML-9. 
Cells stimulated with CCK alone have a 749% ERK2 phosphorylation compared to 
untreated cells. Cells treated with ML-9, CCK, and thapsigargan decrease ERK2 
phosphorylation by 16% over CCK stimulated cells. Thapsigargan alone increased 
only 8.7% compared to untreated cells. Analysis specific for PI3K showed a 30% 
increase in PI3K phosphorylation with CCK compared to untreated cells, a 2% 
decrease in phosphorylation with ML-9, CCK, and thapsigargan (compared to CCK 
W  alone), and a 19% decrease in PI3K phosphorylation with thapsigargan alone
wTime (minutes)
Figure 5. Pancreatic acinar ceils treated with both BDM and CCK for 30 minutes show 
virtually no amylase secretion compared to cells treated with CCK, which show a 35% 
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Table 3. The effect of ML-9 on the phosphorylation of ERK and PI3K, compared to 
cells only stimulated with CCK. Cells treated with ML-9 and CCK showed a 13% 
phosphorylation of ERK and a 26% phosphorylation of PI3K. These were increases in 
tyrosyl phosphorylation compared to cells treated only with CCK.
W
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compared to untreated cells (Table 4).
A final experiment was done to determine whether or not actin filaments are 
necessary for signal transduction. Acinar cells were treated with 30 jxM cytochalasin D
for 40 minutes and zymogen granules were isolated. Cytochalasin D binds to the end 
of actin filaments preventing monomer polymerization. Cells were immunoprecipitated 
with anti-phosphotyrosine antibody and probed using antibodies specific for PI3K. 
Compared to cells that were not treated with cytochalasin D, PI3K had a 75% 
decrease in phosphorylation. This suggests that microfilament need to polymerize to 
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Table 4. The effect of ML-9 and thapslgargan on the tyrosyl phosphorylation of ERK 
and PI3K, compared to cells only stimulated with CCK. Cells treated with ML-9, CCK, 
and thapsigargan showed a 16% phosphorylation of ERK and a 2% phosphorylation 
of PI3K. These were decreases in tyrosyl phosphorylation compared to cells treated 
only with CCK.
DISCUSSION
The pancreas must respond to CCK stimulation by producing digestive 
enzymes while simultaneously initiating enzyme release into the small intestine. After 
systematically altering the cytoskeletal network within pancreatic cells, physiological 
coordination showed a disruption between enzyme production and secretion. The 
potential for denovo enzyme production was measured based on the activation of 
signaling enzymes that lead to gene transcription. The enzymes in the study were 
activated by phosphorylation. Phosphorylation entails covalent attachment of 
phosphate (P04) to a tyrosine residue on the enzyme. This addition of negatively
charged group alters the protein structure resulting in the activation of the catalytic site. 
Initial experiments preventing microtubule polymerization resulted in a dramatic 
decrease in extracellular signal-related kinase (ERK) phosphorylation. ERKs are 
protein serine/threonine kinases that are activated by cell surface receptors. ERKs 
function in signal cascade pathways that lead to the expression of transcription factors 
which direct mRNA synthesis (Duan and Williams, 1994). To maintain signal 
transduction, the results conclusively demonstrated that microtubules are necessary 
for ERK phosphorylation, which leads to mRNA production and eventual enzyme 
synthesis. However, the results suggest that microtubules are not required for the 
entire signal transduction cascade. Disrupting the microtubules did not alter PI3K 
phosphorylation compared to normally treated cells. PI3K kinase resides on the 
plasma membrane and is proximal to ERK on the cascade. Phosphatidylinositol 3- 
kinase (PI3K), belongs to a family of enzymes that are heterodimers and consist of a
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regulatory subunit and a catalytic subunit. PI3K appears to mediate aspects of protein 
trafficking in cells (Lopez-llasaca, 1998). Without a stable microtubule network, cell 
coordination, as well as cellular structure, no longer sustain normal physiological 
signal conduction, preventing both enzyme synthesis and release.
Cells that underwent microfilament inhibition, however, resulted in increased 
signal transduction, but decreased amylase secretion. Instead of simply preventing 
polymerization of microfilaments, cells were treated with BDM to inhibit myosin 
ATPase activity. As a result, the signal cascade continued to phosphorylate PI3K and 
ERK, but vesicles were not being released at the plasma membrane. Myosin ATPase 
activity is not required for ERK or PI3K phosphorylation, which leads to enzyme 
production, but is necessary to transport versicles containing enzymes to the plasma 
W  membrane for secretion. When myosin ATPase activity was blocked with BDM in the 
presence of increased intracellular calcium concentration, ERK and PI3K showed 
significant increased phosphorylation over CCK stimulated cells.
To verify these results, motor proteins were obstructed from moving along actin 
filaments by treating cells with ML-9, an inhibitor of myosin light chain kinase. Both 
ERK and PI3K maintained levels of phosphorylation within cells treated with ML-9. 
Myosin motor proteins are therefore not directly required for phosphorylation of 
signaling enzymes within signal transduction cascade, but theoretically are required 
for vesicle transport to the plasma membrane. Further experiments need to be 
performed that measure amylase release of a cell treated with ML-9 to confirm a 
decrease in cell secretion.
w ’ ML-9 treatment of pancreatic acinar cells with high intracellular calcium caused
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ERK and PI3K phosphorylation to decrease compared to cells treated with CCK or 
high calcium alone. Although mechanistically unclear, increased calcium prevents 
cell phosphorylation in cells that have not myosin motor activity. Therefore, both ML-9 
and BDM, agents that inhibit myosin motor proteins via different mechanisms, cause a 
significant decrease in ERK and PI3K when the calcium secreting signal is high, 
suggesting a feedback relationship.
A final experiment was conducted that prevented actin filament polymerization. 
Similar to cells that had microtubule polymerization inhibited with colchicine, cells 
apparently cannot function appropriately when either element of the cytoskeletal 
network has been depolymerized. Cells treated with cytochalasin D however showed 
decreased PI3K phosphorylation compared to untreated cells. Whereas colchicine 
W  induces microtubule depolymerization but did not alter PI3K phosphorylation. In the 
case of microfilaments, PI3K requires stable microfilament polymerization to be 
activated. This is consistent with reports that the microfilament cytoskeleton can 
promote linkage of numerous signalling molecules into a coordinated complex 
(Torgerson and McNiven, 2000). The results also suggest that ERK is distal to this 
complex.
In response to the disconnection between enzyme production and secretion, a 
form of feedback control possibly governs the two interrelated events under normal 
conditions. The present results would suggest that when secretion increases, a signal 
feedbacks unto the signaling cascade which subsequently increases enzyme 
production. Additionally, if cell secretion falls below a certain level, a feedback 
v , mechanism further increases phosphorylation of signal cascade enzymes. The results
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demonstrated that a dynamic cytoskeleton was required for activation of the ERK 
signalling cascade and synthesis of additional digestive enzymes. The results further 
demonstrate that myosin motor protein activity is necessary to down regulate ERK 
activity in the presence of calcium. In these experiments, disrupting the cytoskeleton 
decreased secretion which hypothetically communicated the feedback signal to 
increase ERK phosphorylation and the increase of enzyme production. Nevertheless, 
further examination of cell physiology needs to occur to precisely identify the feedback 
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